T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
Clinical trial NCT02111850 · COMPLETED
Trial details
- NCT number
- NCT02111850
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-07
- Primary completion
- 2021-03-24
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.